Scientist testing biologic drugs under hood
Media Coverage

The Challenge of Building Better Biologic Drugs

Development costs and time to market continue to put pressure on the biopharma industry, driving the need for innovation in methods and technologies.

As the pipeline of biologics matures, the pharmaceutical industry is expected to see new biotherapeutics that offer improved efficacy. Pressure from the current healthcare environment, however, is pushing the pharmaceutical industry toward lower-cost therapies and faster times to market.

Read the Full Article